Beyond Weight Loss: The New Race to Dominate Metabolic Health
The first chapter of the obesity-drug revolution was dominated by one question: How much weight can a medicine help patients lose? That question propelled GLP-1 therapies into mainstream healthcare and set new expectations for pharmaceutical innovation. But as more treatments enter development, weight-loss efficacy alone may no longer be enough to create meaningful differentiation. The…
